CorWave Company Profile

22:17 EDT 21st October 2018 | BioPortfolio

News Articles [4 Associated News Articles listed on BioPortfolio]

$16M-plus financing secured by CorWave

Bpifrance's Programme d'Investissements d'Avenir has made an investment worth about $16.5 million in French company CorWave.  -More- 

French innovation challenge awards CorWave $3.5M funding

French medtech company CorWave was awarded $3.5 million in financing in the second phase of the Worldwide Innovation Challeng -More- 

CorWave is Set to Receive about $3.5 Million in Financing Through France’s Worldwide Innovation Challenge for Its NovaPulse Program, a Mini-Invasive Solution for Cardiac Support

CorWave, a French medical technology company that develops innovative implanted cardiac support devices for patients suffering from heart failure, announced today that it h...

CorWave’s Next-Generation LVAD, Neptune, Receives Funding

The CALYPSO program will receive 14 million euros to develop CorWave Neptune, a new type of cardiac support to improve the management of patients with severe heart failure, as par...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


More Information about "CorWave" on BioPortfolio

We have published hundreds of CorWave news stories on BioPortfolio along with dozens of CorWave Clinical Trials and PubMed Articles about CorWave for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CorWave Companies in our database. You can also find out about relevant CorWave Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record